Target
Glucose-dependent insulinotropic receptor
Ligand
BDBM180562
Substrate
n/a
Meas. Tech.
AlphaScreen cAMP Assay
pH
7.4±n/a
Temperature
310.15±n/a K
EC50
415±n/a nM
Comments
extracted
Citation
 Grauert, MBakker, RBreitfelder, SBuettner, FEickelmann, PFox, TGrundl, MLehmann-Lintz, TRist, W Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists US Patent  US8772323 Publication Date 7/8/2014 
Target
Name:
Glucose-dependent insulinotropic receptor
Synonyms:
G-protein coupled receptor 119 (GPR119) | GP119_HUMAN | GPR119 | Glucose-dependent insulinotropic receptor
Type:
Protein
Mol. Mass.:
36901.49
Organism:
Homo sapiens (Human)
Description:
Q8TDV5
Residue:
335
Sequence:
MESSFSFGVILAVLASLIIATNTLVAVAVLLLIHKNDGVSLCFTLNLAVADTLIGVAISGLLTDQLSSPSRPTQKTLCSLRMAFVTSSAAASVLTVMLITFDRYLAIKQPFRYLKIMSGFVAGACIAGLWLVSYLIGFLPLGIPMFQQTAYKGQCSFFAVFHPHFVLTLSCVGFFPAMLLFVFFYCDMLKIASMHSQQIRKMEHAGAMAGGYRSPRTPSDFKALRTVSVLIGSFALSWTPFLITGIVQVACQECHLYLVLERYLWLLGVGNSLLNPLIYAYWQKEVRLQLYHMALGVKKVLTSFLLFLSARNCGPERPRESSCHIVTISSSEFDG
  
Inhibitor
Name:
BDBM180562
Synonyms:
US8772323, 89
Type:
Small organic molecule
Emp. Form.:
C18H14ClN3O2
Mol. Mass.:
339.776
SMILES:
CC1CC(=O)NN=C1c1ccc2nc(oc2c1)-c1ccccc1Cl |c:6|
Structure:
Search PDB for entries with ligand similarity: